Antibe Therapeutics (ATBPF) News Today $0.22 0.00 (0.00%) As of 04/16/2025 Add Compare Share Share Headlines Stock AnalysisChartShort InterestBuy This Stock ATBPF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period APLIF Appili Therapeutics Inc.August 23, 2024 | seekingalpha.comANTIBE THERAPEUTICS INC (ATBPF) stock forecast and price targetJuly 19, 2024 | finance.yahoo.comAntibe Announces Appointment of ReceiverApril 24, 2024 | finance.yahoo.comAntibe Announces Appointment of ReceiverApril 24, 2024 | businesswire.comAntibe Provides Update on CCAA ProceedingsApril 19, 2024 | businesswire.comAntibe Announces TSX Delisting ReviewApril 16, 2024 | finance.yahoo.comAntibe Announces Granting of Initial Order Under Companies' Creditors Arrangement ActApril 9, 2024 | businesswire.comAntibe to File an Application for an Initial Order Under Companies' Creditors Arrangement ActApril 9, 2024 | businesswire.comAntibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by NuanceApril 1, 2024 | finance.yahoo.comAntibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine MeetingMarch 20, 2024 | businesswire.comAntibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine MeetingMarch 7, 2024 | businesswire.comAntibe Therapeutics Shares Sink After Arbitration Case LostMarch 4, 2024 | marketwatch.comAntibe Therapeutics Stock (OTC:ATBPF), Insider Trading ActivityFebruary 27, 2024 | benzinga.comAntibe Reports Q3 2024 Interim Financial and Operating ResultsFebruary 14, 2024 | finance.yahoo.comAntibe Reports Q3 2024 Interim Financial and Operating ResultsFebruary 14, 2024 | businesswire.comAntibe Therapeutics reports Q2 resultsNovember 13, 2023 | msn.comAntibe Reports PK Results of First Clinical Study of Otenaproxesul’s New FormulationNovember 9, 2023 | finance.yahoo.comIs Antibe Therapeutics (TSE:ATE) In A Good Position To Deliver On Growth Plans?October 20, 2023 | finance.yahoo.comAntibe Initiates First Clinical Study of Otenaproxesul’s New FormulationOctober 18, 2023 | finance.yahoo.comAntibe Announces Results of 2023 Annual MeetingSeptember 8, 2023 | finance.yahoo.comAntibe Reports Q1 2024 Interim Financial and Operating ResultsAugust 14, 2023 | finance.yahoo.comAntibe Reports 2023 Year-End Results and Business HighlightsJune 29, 2023 | finance.yahoo.comClosing Bell: Antibe Therapeutics Inc down on Tuesday (ATE)April 12, 2023 | theglobeandmail.comClosing Bell: Antibe Therapeutics Inc up on Wednesday (ATE)April 6, 2023 | theglobeandmail.comAntibe Therapeutics Inc. (ATBPF)March 12, 2023 | finance.yahoo.comMaxim Group Reaffirms Their Buy Rating on Antibe Therapeutics (ATBPF)February 16, 2023 | markets.businessinsider.comEchelon Wealth Partners Reaffirms Their Buy Rating on Antibe Therapeutics (ATBPF)February 15, 2023 | markets.businessinsider.comAntibe Therapeutics: Top 25 Undervalued Dividend Stocks on TSX (ATE)February 9, 2023 | theglobeandmail.comAntibe Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX (ATE)February 7, 2023 | theglobeandmail.comATBPF: On Track to Initiate Phase 2 Trial for Otenaproxesul in 1H23…November 22, 2022 | finance.yahoo.comAntibe Provides Development Update for OtenaproxesulOctober 12, 2022 | finance.yahoo.comAntibe Announces Results of 2022 Annual MeetingSeptember 9, 2022 | finance.yahoo.comAntibe Academic Collaborator to Present Clinical Data at PAINWeek 2022September 6, 2022 | finance.yahoo.comATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…July 8, 2022 | finance.yahoo.comWill Antibe Therapeutics (TSE:ATE) Spend Its Cash Wisely?July 2, 2022 | finance.yahoo.comAntibe Therapeutics Reports 2022 Year-End Results and Business HighlightsJune 30, 2022 | finance.yahoo.comAntibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor ConferenceApril 25, 2022 | nz.finance.yahoo.comAntibe Therapeutics GAAP EPS of -$0.09February 15, 2022 | seekingalpha.comAntibe Therapeutics Reports Q3 2022 Interim Financial and Operating ResultsFebruary 14, 2022 | finance.yahoo.comATBPF Real-Time QuotesJanuary 28, 2022 | nasdaq.comATE.TO: Development Plan in Place for Otenaproxesul in Acute Pain…December 1, 2021 | finance.yahoo.comBRIEF-Antibe Therapeutics Provides Update On Otenaproxesul And Expanded Drug PipelineOctober 14, 2021 | msn.comAntibe Therapeutics Provides Update on Otenaproxesul and Expanded Drug PipelineOctober 14, 2021 | finance.yahoo.comAntibe Therapeutics Announces Results of 2021 Annual MeetingAugust 19, 2021 | finance.yahoo.comAntibe Therapeutics Reports Q1 2022 Interim Financial and Operating ResultsAugust 17, 2021 | businesswire.comATE.TO: Unexpected Liver Enzyme Elevations Leads to Pause in AME Trial…August 4, 2021 | finance.yahoo.com Get Antibe Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATBPF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ATBPF Media Mentions By Week ATBPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATBPF News Sentiment▼0.001.13▲Average Medical News Sentiment ATBPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATBPF Articles This Week▼00▲ATBPF Articles Average Week Get the Latest News and Ratings for ATBPF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Antibe Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AADI News Today PYRGF News Today EGRX News Today NWPHF News Today IGC News Today NNVC News Today IBIO News Today MTNB News Today AEON News Today NRBO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ATBPF) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredSell this, buy thatI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antibe Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Antibe Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATBPF Stock Alerts